New Precision Drug for Gastric Cancer Approved in Scotland

by | Jan 22, 2026 | Health

Scotland has approved its first CLDN18.2-targeted therapy for advanced gastric and GEJ cancer, expanding options for patients with HER2-negative disease.
Medscape News UK

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments